Prognostic Value of Post-diagnosis Health-Related Quality of Life for Overall Survival in Breast Cancer: Findings from a 10-Year Prospective Cohort in Korea
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose We aimed to evaluate health-related quality of life (HRQOL) at 1-year post-diagnosis in breast cancer (BC) patients and its association with overall survival using data from the National Cancer Center Hospital. Materials and Methods Data of a BC cohort were first obtained between 2004 and 2006 and followed up. HRQOL was assessed using EORTC QLQ-C30 and BC specific module QLQ-BR23 few days after diagnosis and 1 year after that. We examined and compared the difference in the two HRQOL scores measured for each patient by the patient’s current survival status. The Cox proportional hazards model was fitted to evaluate the impact of HRQOL on survival, with adjustment for baseline HRQOL and other factors. Results Of 299 enrolled patients, 206 responded at 1-year post-diagnosis (80.6%) and were followed up for 11.6 years on average. At 1-year post-diagnosis, survivors had better HRQOL scores than those who died, although their health status was similar at baseline. Survivors reported significant increase 1 year after diagnosis in global health status and emotional scales. Between the groups, functional scales such as physical, role, and emotional were significantly different. Functional scales, including physical (adjusted hazard ratio [aHR], 0.70), role (aHR, 0.68), emotional (aHR, 0.72), and symptom scales, including fatigue (aHR, 1.34), dyspnea (aHR, 1.29), appetite loss (aHR, 1.24) were significantly associated with overall survival. Patients who were less worried about future health had favorable survival (aHR, 0.83). Conclusion Besides treatment-related symptoms, non-medical aspects at 1-year post-diagnosis, including functional well-being and future perspective, are predictive of long-term survival. Intervention to enhance physical, role, and emotional support for women soon after their BC diagnosis might help to improve disease survival outcomes afterwards.
Abstract
Purpose We aimed to evaluate health-related quality of life (HRQOL) at 1-year post-diagnosis in breast cancer (BC) patients and its association with overall survival using data from the National Cancer Center Hospital. Materials and Methods Data of a BC cohort were first obtained between 2004 and 2006 and followed up. HRQOL was assessed using EORTC QLQ-C30 and BC specific module QLQ-BR23 few days after diagnosis and 1 year after that. We examined and compared the difference in the two HRQOL scores measured for each patient by the patient’s current survival status. The Cox proportional hazards model was fitted to evaluate the impact of HRQOL on survival, with adjustment for baseline HRQOL and other factors. Results Of 299 enrolled patients, 206 responded at 1-year post-diagnosis (80.6%) and were followed up for 11.6 years on average. At 1-year post-diagnosis, survivors had better HRQOL scores than those who died, although their health status was similar at baseline. Survivors reported significant increase 1 year after diagnosis in global health status and emotional scales. Between the groups, functional scales such as physical, role, and emotional were significantly different. Functional scales, including physical (adjusted hazard ratio [aHR], 0.70), role (aHR, 0.68), emotional (aHR, 0.72), and symptom scales, including fatigue (aHR, 1.34), dyspnea (aHR, 1.29), appetite loss (aHR, 1.24) were significantly associated with overall survival. Patients who were less worried about future health had favorable survival (aHR, 0.83). Conclusion Besides treatment-related symptoms, non-medical aspects at 1-year post-diagnosis, including functional well-being and future perspective, are predictive of long-term survival. Intervention to enhance physical, role, and emotional support for women soon after their BC diagnosis might help to improve disease survival outcomes afterwards.
참고문헌 (39)
- Gotay CC, "The prognostic significance of patient-reported outcomes in cancer clinical trials", J Clin Oncol, 26, pp.1355~1363 (2008)
- Montazeri A, "Health-related quality of life in breast cancer patients : a bibliographic review of the literature from 1974 to 2007", J Exp Clin Cancer Res, 27, pp.32~ (2008)
- Hahn EA, "Precision of health-related quality-of-life data compared with other clinical measures", Mayo Clin Proc, 82, pp.1244~1254 (2007)
- Sprangers MA, "Disregarding clinical trial-based patientreported outcomes is unwarranted : five advances to substantiate the scientific stringency of quality-of-life measurement", Acta Oncol, 49, pp.155~163 (2010)
- Staren ED, "The prognostic role of quality of life assessment in breast cancer", Breast J, 17, pp.571~578 (2011)
- Fiteni F, "Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients", Eur J Cancer, 52, pp.120~128 (2016)
- Montazeri A, "Experiences from the treatment of cancer", Eur J Cancer Care(Engl), 5, pp.168~175 (1996)
- Montazeri A, "Meaning, purposes and controversies", Eur J Cancer Care(Engl), 5, pp.159~167 (1996)
- Smyth EN, "Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer", Health Qual Life Outcomes, 14, pp.52~ (2016)
- Gupta D, "The prognostic association of health-related quality of life scores with survival in breast cancer", Support Care Cancer, 15, pp.387~393 (2007)
- Luoma ML, "Prognostic value of quality of life scores for time to progression(TTP)and overall survival time(OS)in advanced breast cancer", Eur J Cancer, 39, pp.1370~1376 (2003)
- Coates A, "Improving the quality of life during chemotherapy for advanced breast cancer : a comparison of intermittent and continuous treatment strategies", N Engl J Med, 317, pp.1490~1495 (1987)
- Coates A, "Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group", J Clin Oncol, 10, pp.1833~1838 (1992)
- Coates AS, "Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group", J Clin Oncol, 18, pp.3768~3774 (2000)
- Dancey J, "Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group", Qual Life Res, 6, pp.151~158 (1997)
- Efficace F, "Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population : an international multicenter study", J Clin Oncol, 22, pp.3381~3388 (2004)
- Kramer JA, "Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer", Eur J Cancer, 36, pp.1498~1506 (2000)
- Groenvold M, "Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients", Breast Cancer Res Treat, 105, pp.209~219 (2007)
- Lehto US, "Baseline psychosocial predictors of survival in localised breast cancer", Br J Cancer, 94, pp.1245~1252 (2006)
- Quinten C, "Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials", Lancet Oncol, 10, pp.865~871 (2009)
- Efficace F, "Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer", Eur J Cancer, 40, pp.1021~1030 (2004)
- Lee ES, "Health-related quality of life in survivors with breast cancer 1 year after diagnosis compared with the general population : a prospective cohort study", Ann Surg, 253, pp.101~108 (2011)
- Lee MK, "Social support and depressive mood 1 year after diagnosis of breast cancer compared with the general female population : a prospective cohort study", Support Care Cancer, 19, pp.137992~ (2011)
- Aaronson NK, "The European Organization for Research and Treatment of Cancer QLQ-C30 : a quality-of-life instrument for use in international clinical trials in oncology", J Natl Cancer Inst, 85, pp.365~376 (1993)
- Sprangers MA, "The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module : first results from a three-country field study", J Clin Oncol, 14, pp.2756~2768 (1996)
- Lemieux J, "Quality-of-life measurement in randomized clinical trials in breast cancer : an updated systematic review(2001-2009)", J Natl Cancer Inst, 103, pp.178~231 (2011)
- Yun YH, "Validation of the Korean version of the EORTC QLQ-C30", Qual Life Res, 13, pp.863~868 (2004)
- Yun YH, "Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23)", Support Care Cancer, 12, pp.441~445 (2004)
- Fayers P, "The EORTC QLQ-C30 scoring manual", European Organisation for Research and Treatment of Cancer, ~ (2001)
- Osoba D, "Interpreting the meaningfulness of changes in health-related quality of life scores : lessons from studies in adults", Int J Cancer Suppl, 12, pp.132~137 (1999)
- Gralla RJ, "Interpreting clinical trials in lung cancer: impact of methodology and endpoints", J Thorac Oncol, 2(Suppl 2), pp.51~58 (2007)
- Gupta D, "Association between changes in quality of life scores and survival in non-small cell lung cancer patients", Eur J Cancer Care(Engl), 21, pp.614~622 (2012)
- Zhao W, "Survival prediction of anxious emotion in advanced cancer patients receiving palliative care", Psychooncology, 26, pp.1463~1469 (2017)
- Kim S, "The effect of extension of benefit coverage for cancer patients on health care utilization across different income groups in South Korea", Int J Health Care Finance Econ, 14, pp.161~177 (2014)
- Perrone F, "The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy", Ann Oncol, 27, pp.2224~2229 (2016)
- Ramsey SD, "Financial insolvency as a risk factor for early mortality among patients with cancer", J Clin Oncol, 34, pp.980~986 (2016)
- Chino F, "Self-reported financial burden and satisfaction with care among patients with cancer", Oncologist, 19, pp.41420~ (2014)
- 강단비, "Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study", Cancer Research and Treatment, 50(4), pp.1051~1063 (2018), 대한암학회
- Zafar SY, "The financial toxicity of cancer treatment : a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience", Oncologist, 18, pp.381~390 (2013)